ADAPTABLE Study
912 posts
@ADAPTABLEstudy
A Patient-Centered Pragmatic Clinical Trial
The @ADAPTABLEstudy might be completed, but DCRI’s learnings & secondary analyses are not. Read a Q&A w/ DCRI Exec Dir @texhern to learn about how the demonstration project for @PCORnetwork creates a launch pad for future #clinicalresearch with #EHRs: bit.ly/2RweFb2
How did DCRI design the @ADAPTABLEstudy, the landmark pragmatic trial to determine the right dose of aspirin for people with #heartdisease? Read a Q&A with DCRI Executive Director @texhern: bit.ly/2RweFb2 @PCORnetwork @PCORI #EHRs
DCRI-led @ADAPTABLEstudy presented results at #ACC21 this past weekend. Read a Q&A with DCRI Executive Director @texhern about what we learned from this landmark study conducted with @PCORnetwork: bit.ly/2RweFb2
"We chose outcomes that were important to patients and clinicians alike," DCRI's @schuyler_jones says while sharing additional insights on @ADAPTABLEstudy during an #ACC21 deep dive.
This is the FIRST TIME we have had a participant in a trial present the background for why the study was done and the primary results!
In a trial designed to try to answer Q of optimal dose of #aspirin for secondary prev. in patients with established atherosclerotic #CVD, no significant diff. found in CV events/major bleeding btwn the 81 mg & 325 mg daily doses. bit.ly/3tRJKTH #ADAPTABLE #ACC21 @NEJM
Welcome to the first day of #ACC21! We are excited to hear and present a lot of great science today, including late-breaking results from @adaptablestudy and a couple of interesting panel discussions. Stay tuned! bit.ly/3goxF5q
📣 Starting now on PCT Grand Rounds! "Diverse Representation Among Clinical Trial Participants: Why It Is Important and How We Can Improve" with Dr. Clyde Yancy of @NUFeinbergMed. 🔗 bit.ly/3uCLEss #pctGR
